AstraZeneca
The role leads enterprise deal analytics for US market access contracts, developing pre‑deal models, post‑deal evaluations, and measurement frameworks to connect contract terms with real‑world outcomes. The incumbent partners with contracting, pricing, finance, and legal teams to provide data‑driven insights that drive sustainable growth and patient access.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
Director, Market Access Deal Analytics
Axsome Therapeutics
Deal Team Member
Palantir Technologies
Analyst, Deal Desk & Contract Analytics
Zeta Global
Deal Team Member
Palantir Technologies
Director, Payer Contract Analytics - NECS
AbbVie
Senior Director, Metabolic Market Access Strategy & Marketing
Travere Therapeutics